Nektar Therapeutics 10K 2017 Annual report | NKTR Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: abstract, accrual, adenocarcinoma, Advisory, ADYNOVI, Affordable, allegedly, anniversary, Antitrust, arose, auditor, avoiding, begun, bewteen, borne, category, CHMP, cholangiocarcinoma, CMS, Colombia, concealing, Conference, Congressional, constrain, constraining, core, curtailment, declaratory, declined, defense, defraud, Department, desire, digit, discontinuing, distinct, drafted, ductal, Education, effort, ELOCTATETM, exacerbation, false, formulary, fraudulent, frequency, fundamental, gall, gastric, HALO, HAP, headache, highest, HIPAA, holistically, implicate, inaccurate, introduced, investigatory, ipilimumab, jointly, judgement, KEYTRUDA, kind, knowingly, Korea, likable, mandatory, marketplace, Medicaid, Medicare, mentioned, naldemedine, NCFB, necessity, needy, nominated, noncurrent, nonexclusive, Notwithstanding, ONZEALD, outpatient, owed, payor, PCAOB, PDA, pembrolizumab, phantom, Portability, prejudice, Presidential, principle, privacy, proportionate, prosecuted, prosecution, provisional, purportedly, Reconciliation, recreational, referral, refuse, remeasured, remuneration, repeal, repeatedly, reputational, restructuring, retail, reverted, revised, satisfaction, scheme, scrutiny, searchable, sector, sentence, signify, soliciting, statute, strict, SUMMIT, Sunshine, supersede, superseded, supratherapeutic, surgery, suspected, Symproic, taxation, teaching, tecentriq, Thoracic, transparency, TRICARE, vacancy, violate, violation, waiting, wholesaler, willfully, windfall, wrote, Yervoy

Removed: adjunctive, aerosol, allergic, America, aminoglycoside, antibiotic, antipseudomonal, Asia, Beecham, breathing, brokerage, categorized, closed, conventional, Corium, County, credited, Diabetic, Eleven, ELOCTATE, explained, eye, fall, fine, Forest, gained, generator, gentamycin, Gergel, Industrial, inhalation, insignificant, intensive, investigated, Ivan, levofloxacin, London, longest, Mateo, MBA, mechanical, mid, mortality, moved, multicenter, neovascular, North, oncolytic, originally, OSI, permanently, pro, proportion, QIDP, ranibizumab, rata, Retinopathy, Road, Royal, shortest, SmithKline, solution, sought, span, standardized, terminating, tobramycin, top, topline, vision, week, Wharton

Nektar Therapeutics (NKTR) 10-K2017 FY Annual report

Content analysis